Improving the process and outcome of care in COPD: development of a standardised assessment tool.

INTRODUCTION A major goal of COPD treatment is to reduce symptom burden and ensure that the patient's health is as good as possible. This goal requires regular systematic assessment of the patient's COPD with clear and efficient communication between the patient and clinician. AIM To explore patient and physician descriptions of COPD attributes, in order to inform content development of a patient-reported clinical assessment tool. METHODS Qualitative research methods (one-to-one interviews and patient focus groups) were used to elicit key characteristics to evaluate COPD health status and explore how patients with COPD experience their condition. ATLAS.ti version 5.0 was used to identify major themes and generate an item pool. RESULTS Fifty-eight patients with COPD (GOLD stages 1-4; MRC grades 2-5) and 10 clinicians participated in this research. Twenty-one items were generated, capturing patient assessment of breathlessness, wheeze, cough, sleep, activity limitation, energy/fatigue, social function, and anxiety. CONCLUSIONS This qualitative study identified a broad range of items that are potentially suitable for inclusion in a short, simple COPD assessment tool for use in routine clinical practice.

[1]  W. Bailey,et al.  Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). , 2009, Primary care respiratory journal : journal of the General Practice Airways Group.

[2]  M. Pistolesi,et al.  Outcomes for COPD pharmacological trials: from lung function to biomarkers , 2008, European Respiratory Journal.

[3]  Antonio Anzueto,et al.  Patient's perception of exacerbations of COPD--the PERCEIVE study. , 2006, Respiratory medicine.

[4]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[5]  Dirkje S Postma,et al.  Health and Quality of Life Outcomes , 2003 .

[6]  S. Borg,et al.  Costs of COPD in Sweden according to disease severity. , 2002, Chest.

[7]  M. Decramer,et al.  Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey , 2002, European Respiratory Journal.

[8]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[9]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[10]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[11]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[12]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[13]  Philip Marcus,et al.  Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.